Breaking News, Collaborations & Alliances

Univercells Technologies Partners with TFBS Bioscience

TFBS will leverage scale-X carbo mid-scale fixed-bed bioreactor from Univercells for GMP viral vector operations at the CDMO’s New Taipei City facility.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

TFBS Bioscience, a GMP viral vector contract development and manufacturing organization (CDMO) in the Asia-Pacific (APAC) region providing the first viral vector manufacturing in Taiwan, has entered a partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral production. TFBS will leverage the scale-X carbo mid-scale fixed-bed bioreactor from Univercells for good manufacturing practice (GMP) viral vector operations at the expandin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters